IgG subclass distribution in serum and various mucosal fluids of HIV type 1-infected subjects

AIDS Research and Human Retroviruses

Volumn 16, Issue 6, 2000, Pages 583-594

  Raux, Maurice ^a,e   Finkielsztejn, L ^b   Salmon Ceron D ^b   Bouchez, H ^b   Excler, J L ^c   Dulioust, E ^b   Grouin, J M ^d   Sicard, D ^b   Blondeau, C ^a  

^a SANOFI PASTEUR   (France)

^b Hôpital Cochin ^*  (France)

^c HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^d UNIVERSITÉ DE ROUEN   (France)

^e Clinical Sero Immunology Laboratory   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4;

ADULT; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXUDATES AND TRANSUDATES; FEMALE; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOGLOBULIN G; MALE; MUCOUS MEMBRANE; RECTUM; SALIVA; SEMEN; SERUM ALBUMIN; VAGINA;

EID: 0034630501     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200309007     Document Type: Article

References (40)

1. Mann JM: AIDS - the second decade: A global perspective. J Infect Dis 1992;165:245-250.
2. Mostad SB and Kreiss JK: Shedding of HIV1 in the genital tract. AIDS 1996;10:1305-1315.
3. Forrest D: Women, HIV, and mucosal immunity. Lancet 1991; 337:835-836.
4. McGhee JR, Mestecky J, Derzbaugh MT, Eldridge JH, Hirasawa M, and Kiyono H: The mucosal immune system: From fundamental concepts to vaccine development. Vaccine 1992;10:75-88.
5. Mestecky J and Jackson S: Reassessment of the impact of mucosal immunity in infection with the human immunodeficiency virus (HIV) and design of relevant vaccines. J Clin Immunol 1994; 14:259-272.
6. Kiyono H, Miller C, Lu Y, Lehner T, Cranage M, Huang YT, Kawabata S, Marthas M, Roberts B, Nedrud JG, Lamm ME, Bergmeier L, Brookes R, Tao L, and McGhee JR: The common mucosal immune system for the reproductive tract: Basic principles applied towards AIDS vaccine. Adv Drug Deliv Rev 1995; 18:23-51.
7. Milman G and Sharma O: Mechanisms of HIV/SIV mucosal transmission. AIDS Res Hum Retroviruses 1994;10:1305-1312.
8. Stefanache-Guichard AI: HIV vaccine and genital secretory immune response. Rom J Virol 1995;46:85-98.
9. Essex M: Retroviral vaccines: Challenge for the developing world. AIDS Res Hum Retroviruses 1996;12:361-363.
10. Behets FM, Edidi B, Quinn TC, Atikala L, Bishagara K, Nzila N, Laga M, Piot P, Ryder RW, and Brown CC: Detection of salivary HIV-1 specific IgG antibodies in high risk populations in Zaire. J AIDS 1991;4:183-187.
11. Wolff H, Mayer K, Seage G, Politch J, Horsburgh CH, and Anderson D: A comparison of HIV-1 antibody classes, titers, and specificities in paired semen and blood samples from HIV-1 seropositive men. J AIDS 1992;5:65-69.
12. Lü XS, Bélec L, and Pillot J: Anti-gp160 IgG and IgA antibodies associated with a large increase in total IgG cervicovaginal secretions from human immunodeficiency virus type1-infected women. J Infect Dis 1993;167:1189-1192.
13. Connel JA, Parry JV, Mortimer PP, and Duncam J: Novel assay for the detection of immunoglobulin G anti-human immunodeficiency virus in untreated saliva and urine. J Med Virol 1993;41:159-164.
14. Lü XS, Delfraissy JF, Grangeot-Keros L, Rannon MT, and Pillot J: Rapid and constant detection of HIV antibody response in saliva of HIV infected patients: Selective distribution of anti-HIV activity in the IgG isotype. Res Virol 1994;145:369-377.
15. Mohamed OA, Ashley R, Goldstein A, McElrath J, Dalessio J, and Corey L: Detection of rectal antibodies to HIV-1 by a sensitive chemoluminescent western blot immunodetection method. J AIDS 1994;7:375-380.
16. Bélec L, Dupré T, Prazuck T, Tévi-Bénissan C, Kanga JM, Pathey O, Lu XS, and Pillot J: Cervicovaginal overproduction of specific IgG to human immunodeficiency virus (HIV) contrasts with normal or impaired IgA local response in HIV infection. J Infect Dis 1995;172:691-697.
17. Artenstein AW, VanCott TC, Sitz KV, Robb ML, Wagner KP, Veit SCD, Rogers AF, Garner RP, Byron JW, Burnett PR, and Birx DL: Mucosal immune responses in four distinct compartments of women infected with human immunodeficiency virus type 1: A comparison by site and correlation with clinical information. J Infect Dis 1997;175:265-271.
18. Haimovici F, Mayer KH, and Anderson DJ: Quantitation of HIV-1 specific IgG, IgA and IgM antibodies in human genital tract secretions. J AIDS Hum Retroviral 1997;15:185-191.
19. Schneider T, Zippel T, Schmidt W, Pauli G, Heise W, Wahnschaffe U, Riecken EO, Zeitz M, and Ullrich R: Abnormal predominance of IgG in HIV-specific antibodies produced by short-term cultured duodenal biopsy specimens from HIV-infected patients. J AIDS Hum Retroviral 1997;16:333-339.
20. Raux M, Finkielsztejn L, Salmon-Céron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, and Blondeau C: 1999. Comparison of the distribution of IgG and IgA antibodies in serum and different mucosal fluids of HIV-1 infected subjects. AIDS Res Hum Retroviruses 1999;15:1365-1376.
21. Raux M, Finkielsztejn L, Salmon-Céron D, Bouchez H, Excler JL, Dulioust E, Grouin JM, Sicard D, and Blondeau C: Development and standardization of methods to evaluate the antibody response to an HIV-1 candidate vaccine in secretions and sera of seronegative vaccine recipients. J Immunol Methods 1999:222:111-124.
22. Bélec L, Meillet D, Levy M, Georges AJ, Tévi-Benissan C, and Pillot J: Dilution assessment of cervicovaginal secretions obtained by vaginal washing for immunological assays. Clin Diagn Lab Immunol 1995;2:57-61.
23. Jonard PP, Rambaud JC, Dive C, Vaerman JP, Gallan A, and Delacroix DL: Secretions of immunoglobulin s and plasma proteins from the jejunal mucosa. Transport rate and origin of polymeric immunoglobulin A. J Clin Invest 1984;74:525-535.
24. Aucouturier P, Couderc LJ, Gouet D, Danon F, Gombert J, Matheron S, Saimot AG, Clauvel JP, and Preud'Homme JL: Serum immunoglobulin G subclass dysbalances in the lymphadenopathy syndrome and acquired immune deficiency syndrome. Clin Exp Immunol 1986;63:234-240.
25. French MA: IgG subclasses in acquired immunodeficiency. Pediatr Infect Dis J 1990;9:46-49.
26. Papadea C and Check IJ: Human immunoglobulin G and immunoglobulin G subclasses: Biochemical, genetic, and clinical aspects. CRC Rev Clin Lab Med 1989;27:27-58.
27. Ferrante A, Beard LJ, and Feldman RG: IgG subclass distribution of antibodies to bacterial and viral antigens. Pediatr Infect Dis J 1990;9:16-24.
28. Parkin JM, Helbert M, Hughes CL, and Pinching A: Immuno-globulin G subclass deficiency and susceptibility to pyogenic infections in patients with AIDS-related complex and AIDS. AIDS 1989;3:37-39.
29. Roilides E, Black C, Reimer C, Rubin M, Venzon D, and Pizzo PA: Serum immunoglobulin G subclasses in children infected with human immunodeficiency virus type 1. Pediatr Infect Dis J 1991; 10:134-139.
30. Mathiesen T, Brolinden PA, Rosen J, and Wahren B: Mapping of IgG subclass and T-cell epitopes on HIV proteins by synthetic peptides. Immunology 1989;67:453-459.
31. Lal RB, Heiba IM, Dhawan RR, Smith ES, and Perine PL: IgG subclass responses to human immunodeficiency virus-1 antigens: Lack of IgG2 response to gp41 correlates with clinical manifestastion of disease. Clin Immunol Immunopathol 1991;58:267-277.
32. Ljunggren K, Brolinden PA, Morfeldt-Månson L, Jondal M, and Wahren B: IgG subclass response to HIV in relation to antibody-dependent cellular cytotoxicity at different clinical stages. Clin Exp Immunol 1988;73:343-347.
33. Chiodi F, Mathiesen T, Albert J, Parks E, Norrby E, and Wahren B: IgG subclass responses to a transmembrane protein (gp41) peptide in HIV infection. J Immunol 1989;142:3809-3814.
34. Khalife J, Guy B, Kieny MP, Amiesen JC, Montagnier L, Lecocq JP, and Capron A: Isotypic restriction of the antibody response to human immunodeficiency virus. AIDS Res Hum Retroviruses 1987;4:3-9.
35. Elovaara I, Albert PS, Ranki A, Krohn K, and Seppälä I: HIV-1 specificity of cerebrospinal fluid and serum IgG, IgM, and IgG1-G4 antibodies in relation to clinical disease. J Neurol Sci 1993;117:111-119.
36. Arico M, Caselli D, Marconi M, Avanzini MA, Colombo A, Pasinetti G, Maccabruni A, Rondanelli EG, and Burgio GR: Immunoglobulin G3-specific antibodies as a marker for early diagnosis of HIV infection in children. AIDS 1991;5:1315-1318.
37. Mazzoli S, Trabattoni D, Lo Caputo S, Piconi S, Ble C, Meacci F, Ruzzante S, Salvi A, Semplici F, Longhi R, Fusi ML, Tofani N, Biasin M, Villa ML, Mazzota F, and Clerici M: HIV-specific mucosal and cellular immunity in HIV-seronegative partners of HIV-seropositive individuals. Nature Med 1997;3:1250-1257.
38. Beyrer C, Artenstein AW, Rugpao S, Stephens H, VanCott TC, Robb ML, Rinkaew M, Birx DL, Khamboonruang C, Zimmerman PA, Nelson KE, and Natpratan C: Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. J Infect Dis 1999;179:59-67.
39. Kaul R, Trabattoni D, Bwayo JJ, Arienti D, Zagliani A, Mwangi FM, Kariuki C, Ngugi EN, MacDonald KS, Ball TB, Clerici M, and Plummer FA: HIV-1 specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;13:23-29.
40. Hocini H, Belec L, Iscaki S, Garin B, Pillot J, Becquart P, and Bomsel M: High-level of secretory IgA to block HIV type 1 transcytosis: Contrasting secretory IgA and IgG responses to glycoprotein gp160. AIDS Res Hum Retroviruses 1997;13:1179-1185.